Truvestments Capital’s Bio-Techne TECH Stock Holding History

Truvestments Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-71	Closed	-$3.71K	–	1281
2026 Q1	$3.71K	Hold	71	–	–	﹤0.01%	927
2025 Q4	$4.18K	Hold	71	–	–	﹤0.01%	826
2025 Q3	$3.95K	Buy	+71	New	+$3.8K	﹤0.01%	861

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Truvestments Capital's TECH Position: Q2 2026 in Review

Truvestments Capital sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 71 shares — an estimated $3.71K sold.

Truvestments Capital first reported a position in TECH in Q3 2025 and held it in 3 quarters. The position peaked at $4.18K in Q4 2025. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Truvestments Capital reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Truvestments Capital sold 71 Bio-Techne shares in Q2 2026, an estimated $3.71K.
Truvestments Capital first reported a position in Bio-Techne in Q3 2025 and held it in 3 quarters.
Truvestments Capital's Bio-Techne position peaked at $4.18K in Q4 2025.
597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.